320 related articles for article (PubMed ID: 23135628)
1. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Hur H; Xuan Y; Kim YB; Lee G; Shim W; Yun J; Ham IH; Han SU
Int J Oncol; 2013 Jan; 42(1):44-54. PubMed ID: 23135628
[TBL] [Abstract][Full Text] [Related]
2. Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism.
Xuan Y; Hur H; Ham IH; Yun J; Lee JY; Shim W; Kim YB; Lee G; Han SU; Cho YK
Exp Cell Res; 2014 Feb; 321(2):219-30. PubMed ID: 24342832
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells.
Ho N; Coomber BL
Exp Cell Res; 2015 Feb; 331(1):73-81. PubMed ID: 25536473
[TBL] [Abstract][Full Text] [Related]
4. Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.
Lai JH; Jan HJ; Liu LW; Lee CC; Wang SG; Hueng DY; Cheng YY; Lee HM; Ma HI
Neuro Oncol; 2013 Oct; 15(10):1330-41. PubMed ID: 23911596
[TBL] [Abstract][Full Text] [Related]
5. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
Zhang W; Hu X; Zhou W; Tam KY
J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α.
Škorja Milić N; Dolinar K; Miš K; Matkovič U; Bizjak M; Pavlin M; Podbregar M; Pirkmajer S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445316
[TBL] [Abstract][Full Text] [Related]
8. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation.
Kumar A; Kant S; Singh SM
Chem Biol Interact; 2012 Jul; 199(1):29-37. PubMed ID: 22705712
[TBL] [Abstract][Full Text] [Related]
9. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells.
Won HJ; Ha TK; Kwon SJ; Cho HY; Hur SJ; Baik HH; Suh SI; Ha E; Kim YH
Anticancer Drugs; 2010 Mar; 21(3):270-6. PubMed ID: 20023572
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness.
Kuniyasu T; Nakamura T; Tabuchi Y; Kuroda Y
Cancer; 1998 Oct; 83(7):1300-6. PubMed ID: 9762929
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate dehydrogenase kinase regulates hepatitis C virus replication.
Jung GS; Jeon JH; Choi YK; Jang SY; Park SY; Kim SW; Byun JK; Kim MK; Lee S; Shin EC; Lee IK; Kang YN; Park KG
Sci Rep; 2016 Jul; 6():30846. PubMed ID: 27471054
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer.
Tong J; Xie G; He J; Li J; Pan F; Liang H
J Biomed Biotechnol; 2011; 2011():740564. PubMed ID: 21403907
[TBL] [Abstract][Full Text] [Related]
14. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
[TBL] [Abstract][Full Text] [Related]
15. Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.
Rellinger EJ; Romain C; Choi S; Qiao J; Chung DH
Pediatr Blood Cancer; 2015 Apr; 62(4):581-6. PubMed ID: 25630799
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
Stacpoole PW
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming Energy Metabolism with Synthesized PDK Inhibitors Based on Dichloroacetate Derivatives and Targeted Delivery Systems for Enhanced Cancer Therapy.
She W; Liu T; Li H; Wang Z; Guo Z; Liu Y; Liu Y
J Med Chem; 2023 Nov; 66(21):14683-14699. PubMed ID: 37688544
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer.
Lim JY; Yoon SO; Seol SY; Hong SW; Kim JW; Choi SH; Cho JY
World J Gastroenterol; 2012 Aug; 18(30):4037-43. PubMed ID: 22912555
[TBL] [Abstract][Full Text] [Related]
19. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells.
Haugrud AB; Zhuang Y; Coppock JD; Miskimins WK
Breast Cancer Res Treat; 2014 Oct; 147(3):539-50. PubMed ID: 25212175
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.
Pópulo H; Caldas R; Lopes JM; Pardal J; Máximo V; Soares P
Expert Opin Ther Targets; 2015 Jun; 19(6):733-45. PubMed ID: 25976231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
